| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ribonuclease III activity | 1.92e-05 | 3 | 51 | 2 | GO:0004525 | |
| GeneOntologyMolecularFunction | double-stranded RNA-specific ribonuclease activity | 1.92e-05 | 3 | 51 | 2 | GO:0032296 | |
| GeneOntologyBiologicalProcess | trachea development | 2.12e-05 | 22 | 51 | 3 | GO:0060438 | |
| MousePheno | increased circulating interleukin-13 level | 5.79e-05 | 4 | 44 | 2 | MP:0008608 | |
| MousePheno | abnormal circulating interleukin-3 level | 9.62e-05 | 5 | 44 | 2 | MP:0008622 | |
| MousePheno | increased circulating interleukin-3 level | 9.62e-05 | 5 | 44 | 2 | MP:0008623 | |
| Domain | Ribonuclease_3 | 1.94e-05 | 3 | 48 | 2 | PF00636 | |
| Domain | RIBOc | 1.94e-05 | 3 | 48 | 2 | SM00535 | |
| Domain | RNase_III_dom | 1.94e-05 | 3 | 48 | 2 | IPR000999 | |
| Domain | RNASE_3_1 | 1.94e-05 | 3 | 48 | 2 | PS00517 | |
| Domain | RNASE_3_2 | 1.94e-05 | 3 | 48 | 2 | PS50142 | |
| Domain | - | 1.94e-05 | 3 | 48 | 2 | 1.10.1520.10 | |
| Domain | Myosin_tail_1 | 9.64e-04 | 18 | 48 | 2 | PF01576 | |
| Domain | Myosin_tail | 9.64e-04 | 18 | 48 | 2 | IPR002928 | |
| Domain | DSRM | 1.08e-03 | 19 | 48 | 2 | SM00358 | |
| Domain | dsrm | 1.19e-03 | 20 | 48 | 2 | PF00035 | |
| Domain | DS_RBD | 1.32e-03 | 21 | 48 | 2 | PS50137 | |
| Domain | SANT_dom | 2.02e-03 | 26 | 48 | 2 | IPR017884 | |
| Domain | - | 2.18e-03 | 27 | 48 | 2 | 3.30.160.20 | |
| Domain | dsRBD_dom | 2.34e-03 | 28 | 48 | 2 | IPR014720 | |
| Domain | SANT | 2.34e-03 | 28 | 48 | 2 | PS51293 | |
| Domain | Myb_DNA-binding | 3.65e-03 | 35 | 48 | 2 | PF00249 | |
| Domain | BROMODOMAIN_1 | 4.07e-03 | 37 | 48 | 2 | PS00633 | |
| Domain | Bromodomain | 4.29e-03 | 38 | 48 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 4.98e-03 | 41 | 48 | 2 | PS50014 | |
| Domain | BROMO | 5.22e-03 | 42 | 48 | 2 | SM00297 | |
| Domain | Bromodomain | 5.22e-03 | 42 | 48 | 2 | IPR001487 | |
| Domain | - | 5.22e-03 | 42 | 48 | 2 | 1.20.920.10 | |
| Domain | SANT | 7.32e-03 | 50 | 48 | 2 | SM00717 | |
| Pathway | WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS | 8.93e-05 | 6 | 35 | 2 | M39578 | |
| Pathway | WP_MIRNA_BIOGENESIS | 8.93e-05 | 6 | 35 | 2 | M39416 | |
| Pubmed | 4.85e-08 | 486 | 53 | 9 | 20936779 | ||
| Pubmed | 6.50e-08 | 503 | 53 | 9 | 16964243 | ||
| Pubmed | Stress induces p38 MAPK-mediated phosphorylation and inhibition of Drosha-dependent cell survival. | 2.28e-06 | 2 | 53 | 2 | 25699712 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26718009 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26906421 | ||
| Pubmed | Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells. | 2.28e-06 | 2 | 53 | 2 | 34576018 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22479364 | ||
| Pubmed | Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus. | 2.28e-06 | 2 | 53 | 2 | 25295740 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 34287278 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 32894467 | ||
| Pubmed | The effects of DICER1 and DROSHA polymorphisms on susceptibility to recurrent spontaneous abortion. | 2.28e-06 | 2 | 53 | 2 | 31659796 | |
| Pubmed | Dicer, Drosha, and outcomes in patients with ovarian cancer. | 2.28e-06 | 2 | 53 | 2 | 19092150 | |
| Pubmed | Dysregulated expression of dicer and drosha in breast cancer. | 2.28e-06 | 2 | 53 | 2 | 21898071 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 24725360 | ||
| Pubmed | Expression of DROSHA and DICER genes in peripheral blood leukocytes in lung sarcoidosis. | 2.28e-06 | 2 | 53 | 2 | 30701851 | |
| Pubmed | siRNA release from pri-miRNA scaffolds is controlled by the sequence and structure of RNA. | 2.28e-06 | 2 | 53 | 2 | 26921501 | |
| Pubmed | Alternative initiation and splicing in dicer gene expression in human breast cells. | 2.28e-06 | 2 | 53 | 2 | 15987463 | |
| Pubmed | Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. | 2.28e-06 | 2 | 53 | 2 | 18434510 | |
| Pubmed | Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins. | 2.28e-06 | 2 | 53 | 2 | 28448850 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23266047 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 15292197 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 31013297 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 23349018 | ||
| Pubmed | Sequence features of Drosha and Dicer cleavage sites affect the complexity of isomiRs. | 2.28e-06 | 2 | 53 | 2 | 25867481 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 25190313 | ||
| Pubmed | DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases. | 2.28e-06 | 2 | 53 | 2 | 27808570 | |
| Pubmed | Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer. | 2.28e-06 | 2 | 53 | 2 | 20210522 | |
| Pubmed | Murine follicular development requires oocyte DICER, but not DROSHA. | 2.28e-06 | 2 | 53 | 2 | 24990804 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 33535080 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 37099569 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 21544061 | ||
| Pubmed | Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human. | 2.28e-06 | 2 | 53 | 2 | 24981203 | |
| Pubmed | Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer. | 2.28e-06 | 2 | 53 | 2 | 21559780 | |
| Pubmed | Dynamic microRNA gene transcription and processing during T cell development. | 2.28e-06 | 2 | 53 | 2 | 22379031 | |
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 38416826 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 26156018 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 17060477 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 29892896 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 22381205 | ||
| Pubmed | 2.28e-06 | 2 | 53 | 2 | 20805302 | ||
| Pubmed | The microRNA-processing enzymes: Drosha and Dicer can predict prognosis of nasopharyngeal carcinoma. | 2.28e-06 | 2 | 53 | 2 | 21953080 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 2.36e-06 | 774 | 53 | 9 | 15302935 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 2.68e-06 | 582 | 53 | 8 | 20467437 | |
| Pubmed | 6.23e-06 | 653 | 53 | 8 | 22586326 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25439752 | ||
| Pubmed | MicroRNA binding to the HIV-1 Gag protein inhibits Gag assembly and virus production. | 6.83e-06 | 3 | 53 | 2 | 24938790 | |
| Pubmed | ERK1/2 activation is a therapeutic target in age-related macular degeneration. | 6.83e-06 | 3 | 53 | 2 | 22869729 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 25656609 | ||
| Pubmed | Drosha regulates neurogenesis by controlling neurogenin 2 expression independent of microRNAs. | 6.83e-06 | 3 | 53 | 2 | 22706270 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 31250375 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 24769857 | ||
| Pubmed | Restoration of IRF1-dependent anticancer effects by MEK inhibition in human cancer cells. | 6.83e-06 | 3 | 53 | 2 | 25497010 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22394132 | ||
| Pubmed | The RNase III enzyme DROSHA is essential for microRNA production and spermatogenesis. | 6.83e-06 | 3 | 53 | 2 | 22665486 | |
| Pubmed | Re-evaluation of the roles of DROSHA, Export in 5, and DICER in microRNA biogenesis. | 6.83e-06 | 3 | 53 | 2 | 26976605 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 30295958 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 26437240 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22434867 | ||
| Pubmed | Complexity in regulation of microRNA machinery components in invasive breast carcinoma. | 6.83e-06 | 3 | 53 | 2 | 24574065 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22371183 | ||
| Pubmed | Expression of the microRNA regulators Drosha, Dicer and Ago2 in non-small cell lung carcinomas. | 6.83e-06 | 3 | 53 | 2 | 26227789 | |
| Pubmed | Pineoblastoma is uniquely tolerant of mutually exclusive loss of DICER1, DROSHA or DGCR8. | 6.83e-06 | 3 | 53 | 2 | 32124011 | |
| Pubmed | Canonical and alternate functions of the microRNA biogenesis machinery. | 6.83e-06 | 3 | 53 | 2 | 20713509 | |
| Pubmed | Investigation of AID, Dicer, and Drosha Expressions in Patients with Chronic Lymphocytic Leukemia. | 6.83e-06 | 3 | 53 | 2 | 28388279 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 27173348 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 22766726 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 34855193 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 21788498 | ||
| Pubmed | Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas. | 6.83e-06 | 3 | 53 | 2 | 21769619 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 32817626 | ||
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 24807907 | ||
| Pubmed | Transcript Level of MicroRNA Processing Elements in Gastric Cancer. | 6.83e-06 | 3 | 53 | 2 | 30168106 | |
| Pubmed | 6.83e-06 | 3 | 53 | 2 | 23663110 | ||
| Pubmed | 1.20e-05 | 335 | 53 | 6 | 15741177 | ||
| Pubmed | Dicer and Drosha expression in patients with nephrotic syndrome. | 1.36e-05 | 4 | 53 | 2 | 32412691 | |
| Pubmed | Argonaute, Dicer, and Drosha are up-regulated along tumor progression in serous ovarian carcinoma. | 1.36e-05 | 4 | 53 | 2 | 22647351 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 26511315 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 20699384 | ||
| Pubmed | PTEN modulates miR-21 processing via RNA-regulatory protein RNH1. | 1.36e-05 | 4 | 53 | 2 | 22162762 | |
| Pubmed | Ars2 maintains neural stem-cell identity through direct transcriptional activation of Sox2. | 1.36e-05 | 4 | 53 | 2 | 22198669 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 36989574 | ||
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 26147304 | ||
| Pubmed | Multipotency of Adult Hippocampal NSCs In Vivo Is Restricted by Drosha/NFIB. | 1.36e-05 | 4 | 53 | 2 | 27545503 | |
| Pubmed | 1.36e-05 | 4 | 53 | 2 | 32770606 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 21224381 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 27880903 | ||
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 20031576 | ||
| Pubmed | The RNAseIII enzyme Drosha is critical in T cells for preventing lethal inflammatory disease. | 2.27e-05 | 5 | 53 | 2 | 18725527 | |
| Pubmed | 2.27e-05 | 5 | 53 | 2 | 28716689 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | 2.66e-05 | 1321 | 53 | 10 | 27173435 | |
| Pubmed | New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. | 3.40e-05 | 6 | 53 | 2 | 30046112 | |
| Pubmed | Upregulation of Cyclin B1 by miRNA and its implications in cancer. | 3.40e-05 | 6 | 53 | 2 | 22053081 | |
| Pubmed | 3.40e-05 | 6 | 53 | 2 | 29321274 | ||
| Pubmed | Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. | 3.40e-05 | 6 | 53 | 2 | 26773046 | |
| Pubmed | 3.47e-05 | 1084 | 53 | 9 | 11544199 | ||
| Pubmed | 4.39e-05 | 255 | 53 | 5 | 15324660 | ||
| Pubmed | 4.59e-05 | 129 | 53 | 4 | 23022380 | ||
| Pubmed | 4.76e-05 | 7 | 53 | 2 | 22022502 | ||
| Pubmed | P38MAPK-dependent phosphorylation and degradation of SRC-3/AIB1 and RARalpha-mediated transcription. | 6.34e-05 | 8 | 53 | 2 | 16456540 | |
| Pubmed | 6.34e-05 | 8 | 53 | 2 | 20211803 | ||
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.15e-07 | 194 | 53 | 6 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-06 | 177 | 53 | 5 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.32e-06 | 179 | 53 | 5 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.80e-06 | 186 | 53 | 5 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | droplet-Thymus-nan-18m-Myeloid-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.87e-06 | 187 | 53 | 5 | ed69e7cbd6fb59363b0e26f24887fc49405397ce | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.87e-06 | 187 | 53 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.89e-06 | 199 | 53 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.89e-06 | 199 | 53 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | PND01-03-samps-Epithelial-Alveolar_epithelial-AT1_-_meso|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 3.06e-05 | 150 | 53 | 4 | 6a13e4c4b9c9e54a5016573a37132465ec1c8f99 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.23e-05 | 163 | 53 | 4 | aa5ea367f787c1543afb7eb80a801432e1c44011 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.10e-05 | 171 | 53 | 4 | bdd30100b74e012eec3090799c22635aa57fa91d | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 172 | 53 | 4 | a9e65201ad9ab4f64251aba2c0bb3d8f9e0193b6 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.22e-05 | 172 | 53 | 4 | 26006967d0c82f7bd9b36a18e97a1b93e856aa67 | |
| ToppCell | droplet-Lung-LUNG-30m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 176 | 53 | 4 | 5201f003192c033655ba47f0faf8c47a96eae03d | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-05 | 176 | 53 | 4 | 941e8724b6f680719ef2a4f190f943b205bb9e78 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.83e-05 | 177 | 53 | 4 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 178 | 53 | 4 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.09e-05 | 179 | 53 | 4 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.36e-05 | 181 | 53 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | Control-Classical_Monocyte-cMono_4|Control / Disease condition and Cell class | 6.36e-05 | 181 | 53 | 4 | f3e1d8fe5cf1eba19e51c3680a55306cae687fe9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.64e-05 | 183 | 53 | 4 | 54782c2e23bbeca5b683aa931393b1118da4aa37 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.64e-05 | 183 | 53 | 4 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.64e-05 | 183 | 53 | 4 | e91f00b75d43ee6293fdd4a129b789cd95f8d11a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-05 | 184 | 53 | 4 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.78e-05 | 184 | 53 | 4 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | Control-Epithelial_alveolar-AT_2-Differentiating_AT2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-05 | 185 | 53 | 4 | 0d2add28ac1f4fa6de7699be009bf8391badaf4c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.92e-05 | 185 | 53 | 4 | 636505a3d96f75d951ab42bcf8af6ae07abc732d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.92e-05 | 185 | 53 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-05 | 186 | 53 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 187 | 53 | 4 | 201ff693e4756ee3e44762885b3a303a77eb535b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.22e-05 | 187 | 53 | 4 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.37e-05 | 188 | 53 | 4 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.52e-05 | 189 | 53 | 4 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.52e-05 | 189 | 53 | 4 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 7.83e-05 | 191 | 53 | 4 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.83e-05 | 191 | 53 | 4 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.99e-05 | 192 | 53 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | E15.5-Epithelial|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.99e-05 | 192 | 53 | 4 | 3f2ecd428c0c608d7bbd7b403a07399b87761338 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 7.99e-05 | 192 | 53 | 4 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | 2bfac6b3956265205ca47d06888851ed68b65999 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.99e-05 | 192 | 53 | 4 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.99e-05 | 192 | 53 | 4 | d525f7f088a53110912600a7c9f6d33b9270d534 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.15e-05 | 193 | 53 | 4 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.32e-05 | 194 | 53 | 4 | c8b9551b93a5aed62154b487db90130604a6125c | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 8.49e-05 | 195 | 53 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.65e-05 | 196 | 53 | 4 | ed76eeb37400ca154feae9b7ebaddb6c434f8b81 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-05 | 196 | 53 | 4 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | PCW_10-12-Epithelial|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.65e-05 | 196 | 53 | 4 | 9bfb31ff3e4f2c0a9405c418c86bfec5dbca23e2 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.65e-05 | 196 | 53 | 4 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.83e-05 | 197 | 53 | 4 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 9.00e-05 | 198 | 53 | 4 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.00e-05 | 198 | 53 | 4 | 54228dd9a50616d2022712d162a419ed0327cabd | |
| ToppCell | PCW_13-14-Epithelial|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.00e-05 | 198 | 53 | 4 | 48eb6f69a464a34ab32e8d425a22b9d45ec20428 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-05 | 198 | 53 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-05 | 198 | 53 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 9.00e-05 | 198 | 53 | 4 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-05 | 198 | 53 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-05 | 198 | 53 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 5f7da3eab58ace6cddb3179a415cd839d5767958 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.18e-05 | 199 | 53 | 4 | aca81a879ef9c196bd1885eff4c63ffe6c9682b7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Mesenchymal-Cilia-bearing_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 9.18e-05 | 199 | 53 | 4 | 2d8ab4aee300c7c4baf662940ce855da2b6d2cae | |
| ToppCell | Bronchial-10x5prime-Epithelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.36e-05 | 200 | 53 | 4 | d3ee5f79513e2ac02ad3329b59e6290d457c44d2 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.36e-05 | 200 | 53 | 4 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 9.36e-05 | 200 | 53 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.36e-05 | 200 | 53 | 4 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Cilia-bearing_cell|3m / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 0d14a950172a56b11fdebee8f4e13b0c10e0d592 | |
| ToppCell | distal-2-Epithelial|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 9.36e-05 | 200 | 53 | 4 | 2fc1e95706f212bf18ecdf6eb5b3182ac98c9b52 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Mesenchymal-Cilia-bearing_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | c6060205cab46628d845edbf17e2c5be7508181c | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.36e-05 | 200 | 53 | 4 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 9.36e-05 | 200 | 53 | 4 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.97e-04 | 130 | 53 | 3 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Control-Classical_Monocyte-|Control / Disease condition and Cell class | 4.97e-04 | 130 | 53 | 3 | e55f522dab5a6c3af30ad87ac8b32166f660c314 | |
| ToppCell | Control-Classical_Monocyte-|Classical_Monocyte / Disease condition and Cell class | 4.97e-04 | 130 | 53 | 3 | 4433b40b099845f113993b6ecf85ec594b4b9219 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.69e-04 | 144 | 53 | 3 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor|bone_marrow / Manually curated celltypes from each tissue | 6.96e-04 | 146 | 53 | 3 | 035393166f3ad5ab95602a8ae11b7d0ee4b1d691 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.24e-04 | 148 | 53 | 3 | 18cfecd6ae20edb74f5d44ba759909df356acf3a | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.13e-04 | 154 | 53 | 3 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | 5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.43e-04 | 156 | 53 | 3 | d411116d54add2d4fe649a97ac54cb94c085312f | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 8.59e-04 | 157 | 53 | 3 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l8|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.59e-04 | 157 | 53 | 3 | 5098675f64342c41c5ca3551b24962d10c83e64d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.07e-04 | 160 | 53 | 3 | 6ed37d1fd0304932319d6b942502404115ff36a7 | |
| ToppCell | Leuk-UTI-Myeloid-tDC|Leuk-UTI / Disease, Lineage and Cell Type | 9.24e-04 | 161 | 53 | 3 | 51b9f60986ed2e8e2297d31c80462c3ab65a2e5e | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.24e-04 | 161 | 53 | 3 | 66554f59eaea4ba55a6c6724f9368e24e99c91e9 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 9.41e-04 | 162 | 53 | 3 | 2259e9536147e9cdee772e3a30ba7d104573262c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.41e-04 | 162 | 53 | 3 | 80317c4253bf8e897782e562f29835f181c65b98 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.57e-04 | 163 | 53 | 3 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 9.57e-04 | 163 | 53 | 3 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.57e-04 | 163 | 53 | 3 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-04 | 164 | 53 | 3 | beaa13a75c3bb72446c85084d75e9fe3f15fd3d4 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-A_(AT2)|343B / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-04 | 164 | 53 | 3 | d005cfd821b87548b075120bffe65a0be9860463 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 9.92e-04 | 165 | 53 | 3 | 6799a6580c667738995cceb31cbf1c7fbdc4ff84 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.92e-04 | 165 | 53 | 3 | 8329d780f244bc31344443b29e5a00529a016662 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-04 | 165 | 53 | 3 | 84eca6a0f5e996b6955ae79fa102af239098fe8f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-04 | 165 | 53 | 3 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.92e-04 | 165 | 53 | 3 | af59a095ecc6758abc13d763c00e44447c488167 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-04 | 165 | 53 | 3 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.92e-04 | 165 | 53 | 3 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 3.17e-06 | 178 | 52 | 6 | 3998_DN | |
| Drug | Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A | 4.34e-06 | 188 | 52 | 6 | 6735_DN | |
| Disease | Rhabdomyosarcoma | 2.91e-04 | 15 | 50 | 2 | C0035412 | |
| Disease | neutrophil count | 4.66e-04 | 1382 | 50 | 9 | EFO_0004833 | |
| Disease | Anhedonia | 7.58e-04 | 24 | 50 | 2 | C0178417 | |
| Disease | Lung Neoplasms | 1.06e-03 | 265 | 50 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.07e-03 | 266 | 50 | 4 | C0242379 | |
| Disease | cancer (implicated_via_orthology) | 1.10e-03 | 268 | 50 | 4 | DOID:162 (implicated_via_orthology) | |
| Disease | Bilateral Wilms Tumor | 1.11e-03 | 29 | 50 | 2 | C2930471 | |
| Disease | muscular atrophy (biomarker_via_orthology) | 1.11e-03 | 29 | 50 | 2 | DOID:767 (biomarker_via_orthology) | |
| Disease | mean platelet volume | 1.58e-03 | 1020 | 50 | 7 | EFO_0004584 | |
| Disease | Nephroblastoma | 1.71e-03 | 36 | 50 | 2 | C0027708 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EDRPMPKLEIEKEIE | 746 | O60566 | |
| MEDPKEIRKEELEED | 386 | Q8WY36 | |
| LGPAVDKDKEALMEE | 661 | Q8TD16 | |
| PSIDGKEELDLAEKM | 386 | Q9H0E9 | |
| EGIPSENEEEKKMLD | 2341 | Q12802 | |
| MLPDLKEKENDELDI | 361 | O60879 | |
| EEKEEDIEVPKAMGD | 1796 | Q9UPY3 | |
| EKLDESMERPESPKE | 1301 | Q9BXF3 | |
| RMDLEEPEKVDKLQE | 341 | P13631 | |
| DEDEEGKLPEDIMKL | 226 | P10914 | |
| EVMGEDIPEKIKDEV | 316 | Q96K31 | |
| DPLGDKEIKDVKEMF | 641 | P98082 | |
| FDMELDDLPKEKLKE | 331 | P28482 | |
| LELPEDEEEKKKMEE | 541 | P08238 | |
| KEMPKDLVVIEDEDE | 291 | Q99607 | |
| LPEDEEEKKIMEESN | 451 | Q58FF6 | |
| EGVESDDLKKDLPLM | 1976 | Q2LD37 | |
| PPKEESKDEIEEMVL | 21 | Q8N4E4 | |
| EGEELEELMKLSPEE | 256 | Q14651 | |
| IMEEVVKLEKDPDLE | 1461 | Q92817 | |
| EIPKGDDELAIDVMD | 721 | O94915 | |
| EGELVLPDLEKDDMI | 556 | Q8WWI1 | |
| KELPIDEDEEMKDLL | 846 | Q9UL01 | |
| EDLEKEGTMPLEDLL | 56 | Q7Z3K6 | |
| DELPDMTLDKEEIAK | 96 | Q7Z3K6 | |
| KPDTDEAEDPEKMLA | 576 | Q9BUQ8 | |
| PGKLLPDEILEDDME | 371 | C9JSJ3 | |
| MDDPKKEDILLLADE | 1 | Q9NYZ3 | |
| ELEKGKMPIDLVIED | 146 | A8K0S8 | |
| PPSEDISLDEKKEME | 2641 | Q4G0P3 | |
| FLDLEDLDMDEEIKP | 101 | Q86VG3 | |
| KLPSKVLDDMDDDDD | 1261 | Q0VF96 | |
| EEEEKEERKRGPMET | 136 | I3L3R5 | |
| IDLDELMKKDEPPLD | 41 | Q8WUF8 | |
| GMDEELDSPEELGKK | 1106 | Q12955 | |
| EEERLMEAEKAKPDA | 281 | Q8IY82 | |
| EEEELEIELMGETPK | 316 | Q8TEX9 | |
| KMKPIEEGAEDDDDV | 331 | Q8NE79 | |
| NMPKEEEEEEKEGRH | 686 | Q96P20 | |
| MPDKNEEEEEELLKP | 396 | Q9NRR4 | |
| KEELEEEEKMREDGG | 21 | Q9NX52 | |
| LPKDDQELEELMLEE | 496 | Q13275 | |
| LTKEEEKKQPDEEPM | 451 | O60502 | |
| EEKPEETPKMELSLE | 1881 | Q5UIP0 | |
| KDDEEMDIDTVKKLP | 81 | O95149 | |
| EKLEGAEEEKMEADP | 771 | Q92922 | |
| KLADIDKDGMLDDDE | 486 | Q9NZN3 | |
| KEEMEEELGEKIEVL | 596 | Q9P2M7 | |
| EKAALEKPMDLEEEK | 526 | O14967 | |
| EEMLKDKGKPESEGE | 56 | Q96EI5 | |
| EKPTKEKEEEDMELT | 841 | Q9HCF6 | |
| LEEKVEHLEEGPMIE | 96 | Q9Y6G3 | |
| EEMEDRLQALEKDKP | 441 | P13489 | |
| EMEVEPARKGEEEQK | 221 | Q13105 | |
| REVLGMEELEKLPEE | 366 | Q9H8Y1 | |
| MDQDEPLEVKIEEEK | 11 | O43309 | |
| MKEEEPAEGKKSEDD | 206 | Q7Z7E8 |